Intravenous administration of n-acetylcysteine [3] (multiple letters)

Annals of Emergency Medicine

Volumn 46, Issue 2, 2005, Pages 207-208

  Crouch, Barbara Insley ^a   Rusho, William J ^b   Lavonas, Eric J ^c   Beuhler, Michael C ^c   Ford, Marsha D ^c   Kerns II, William P ^c   Rouse, Anna M ^c   Tomaszewski, Christian A ^c   Wittler, Mary A ^c  

^a Utah Poison Control Center   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Carolinas Poison Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE;

DRUG APPROVAL; DRUG COST; DRUG FORMULATION; DRUG LEGISLATION; DRUG SAFETY; DRUG USE; INTOXICATION; LETTER; PRIORITY JOURNAL; VOMITING;

EID: 22844432737     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2005.02.027     Document Type: Letter

References (4)

1. E.J. Lavonas M.C. Beuhler M.D. Ford Intravenous administration of N- acetylcysteine: oral and parenteral formulations are both acceptable Ann Emerg Med 45 2005 223 224
2. W.A. Watson T.L. Litovitz W. Klein-Schwartz 2003 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System Am J Emerg Med 22 2004 335 404
3. US Food and Drug Administration/Center for Drug Evaluation and Research. The practice of pharmacy compounding [US Food and Drug Administration Web site]. Available at: http://www.fda.gov/cder/pharmcomp/default.htm . Accessed February 17, 2005.
4. US Food and Drug Administration/Center for Drug Evaluation and Research. The FDA Compliance Policy Guide [US Food and Drug Administration Web site]. Available at: http://www.fda.gov/ora/compliance_ref/cpg/cpgdrg/cpg460-200.html . Accessed February 18, 2005.